200 - CARDIOGENIC SHOCK- TAKE II

Panelist(s)

• 

  Andrea Daly, MD (she/her/hers)

  Trillium Health Partners
  University of Toronto
• 

  Anique Ducharme, MD, MSc

  Director oh Heart Failure Clinic
  Montreal Heart Institute
  University of Montreal

Presenter(s)

• 

  Mena Gewarges, MD (she/her/hers)

  Cardiologist
  CANCARE
  University of Toronto

Panelist(s)

• 

  Chris Overgaard, MD, MSc., FRCPC (he/him/his)

  Chief, Department of Cardiac Health, Southlake Health
  CAIC, CANCARE
  University of Toronto
• MP

  Maude Peretz-Larochelle, MD, FRCPC

  CARDIOLOGIST
  CCS, CANCARE
  McGill University
• 

  Janek Senaratne, MD, MSc, FESC, FACC, FCCS

  Associate Clinical Professor of Medicine and Critical Care Medicine
  CANCARE
  University of Alberta

Presenter(s)

• TA

  Tauben Averbuch, MD

  Clinical Fellow
  University of Toronto
  University of Toronto
• DB

  Darshan Brahmbhatt, MB BChir, MD(Res)

  Cardiologist
  University Health Network (UHN)
  University of Toronto & Mount Sinai Hospital
• TR

  Thomas Roston, MD, PhD

  Clinical Assistant Professor
  UBC
• 

  Gurmeet Singh, MD, MSc, FRCSC, FCCS

  Associate Clinical Professor
  University of Alberta
  University of Alberta

Moderator(s)

• KA

  Kim Anderson, MD (she/her/hers)

  Cardiologist
  Dalhousie University
  Dalhousie University
• 

  Mustafa Toma, MD FRCPC

  Clinical Professor – UBC; Director, Cardiac Intensive Care Unit - SPH
  CCS, CCTN, CHFS
  University of British Columbia

Planning Committee Member(s)

• 

  Filio Billia, MD, PhD (she/her/hers)

  Clinician-Scientist
  University Health Network (UHN)
• 

  Yoan Lamarche, MD, MSc

  Cardiac surgeon and Intensivist
  Montreal Heart Institute
  Montreal Heart Institute
• DN

  Dave Nagpal, MD

  Cardiac Surgery / Critical Care Medicine
  CCS, CSCS, CANCARE, CCTN
  Western University
• 

  Sean Van Diepen, MD, FRCPC

  Associate Professor
  University of Alberta
  University of Alberta

Workshop Description: Cardiogenic shock is a life-threatening condition where impaired heart function leads to inadequate end-organ perfusion. However, cardiogenic shock needs differing considerations depending on etiology, choice of MCS and decision making in general. Furthermore, systems of care processes need to be implemented to transfer patients to MCS centers that can manage these patients appropriately with adequate resources.
This symposium is designed for all health care providers who care for patients in cardiogenic shock, particularly in a critical care setting. We will present a clinical case followed by didactic sessions that will outline the issues pertaining to managing patients with different etiologies of cardiogenic shock. Furthermore, we will discuss the importance of collaborative care between hub and spoke centers in order to outline the importance of timely referral. Finally, we will explore differing management opinions in the form of a debate.